Mass Spectrometry Of Drugs, Natural Products, Proteins,

药物、天然产物、蛋白质的质谱分析,

基本信息

项目摘要

The Structural Mass Spectrometry Group now concentrates almost entirely on peptide and protein type samples. These may come to the laboratory as spots on gels, recombinant protein samples for structural confirmation or post-translational modification determination, as proteins or protein complexes precipitated or purified with antibodies, or as entire proteomes. Spots on gels are routinely identified by digestion of the spot with trypsin, after reduction and alkylation, and subsequent analysis on the QTOF mass spectrometer in the group. These MS/MS results (including sequence data from the peptides) can be searched on in-house software or against the new NIH Mascot server. Our group has specialized in identifying the post-translational modifications in proteins. In particular, we have examined many proteins and characterized their disulfides. We also are working hard to develop methods for the characterization of glycosylation sites. N-linked glycoforms are easily removed with PGNaseF, and the Asn is changed to an Asp thereby leaving a marker. O-linked sites are lost after the glycosylation is removed. Our laboratory is working on a project to improve methods of positively identifying both N- and O-linked sites. We have a specific interest in not only identifying the sites, but also in determining all of the glyco-structures on these peptides. Work is underway to develope the techniques for this approach, including the development of software to aid in the interpretation. Other software on the laboratory web site at http://sx102a.niddk.nih.gov continues to be in heavy demand. As an increased understanding of protein interactions becomes known, the importance of isolating protein complexes and identifying the players is of big interest. The group is interacting with several research groups working in this area and developing the techniques to deal with these samples. Of particular interest is the identification of all the proteins in a specific proteome. The common approach is to digest an entire proteome with trypsin and then fractionate this by two dimensional chromatography. This method ?discards? all the chromatographic information as the entire 2-D liquid chromatographic run must be analyzed as one search set. We have chosen to pre-separate the proteins in the proteome using reverse phase (C18) chromatography and separately digest and characterize each fraction, as this should give a more concise and accurate search. After using some trial protein mixtures, we chose to use the proteome of Rickettsia. Reckettsia is a class B biowarfare agent and thus very relevant to NIH following the new initiatives here. Protein samples were supplied from the University of South Alabama and involved just the soluble proteins. Of the 834 proteins in the proteome, 53 were identified in the initial trial run using fast chromatography and limited data acquisition. This number expanded a little when longer chromatographic runs were tried but the method is far from optimized. However this ?proteome? methodology is far from optimized and will be the subject of further development work. For full details of the results so far, view the web site at http://sx102a.niddk.nih.gov/proteome.html. Other projects include: (1) The characterization of cyclized Green Fluorescent Protein (GFP), which is also being used as a tag for proteomic approaches. Cyclase Associated Protein, mutant cyanovirin and dihydrofolate reductase have been effectively characterized. (2) The characterization of the molecular structure of silk proteins. This required the development of methods to determine isotopically enriched proteins. (3) A similar method has been established to identify and characterize abnormal amino acids found in natural products targeted for their anti-HIV and anti-cancer activity. (4) We are working on methods to elucidate structural information of HIV-integrase cross-linked with DNA and Actinomyces naeslundii fimbriae. (5) In order to identify the most reactive sites in tubulin, every cysteine in the tubulin has been reacted with various sulfhydryl reagents. This method will be a very important tool in protein-drug binding studies as well as for understanding tubulin polymerization mechanism. (6) A method to characterize fluxes of palmitoylation of the TRH receptor is under investigation. This research is important to understand how and why post-translational modifications are triggered by environmental changes. The laboratory runs a large number of more rountine analyses, helping investigators from all over NIH. The demand for characterization of proteins has increased so dramatically that a new LCMS obtained from elsewhere in the Institute has been set up in our group for hands-on use by those investigators. The QTOF instrument, which was jointly purchased by five institutes, runs on an almost continuous basis.
现在,结构质谱组几乎完全集中在肽和蛋白质型样品上。这些可能作为凝胶上的斑点,重组蛋白样品的结构确认或翻译后修饰测定,作为蛋白质或蛋白质复合物沉淀或用抗体纯化的蛋白质或整个蛋白质组织。 凝胶上的斑点通常通过胰蛋白酶,还原和烷基化后的斑点消化,以及该组中QTOF质谱仪的随后分析。这些MS/MS结果(包括来自肽的序列数据)可以在内部软件或针对新的NIH Mascot服务器上进行搜索。我们的小组专门识别蛋白质的翻译后修饰。特别是,我们检查了许多蛋白质并表征了它们的二硫化物。我们还在努力开发用于表征糖基化位点的方法。使用PGNASEF很容易去除N连锁的糖衣,然后将ASN更改为ASP,从而留下标记。去除糖基化后,O连锁位点丢失。我们的实验室正在研究一个项目,以改善积极识别N-和O链接站点的方法。我们对不仅识别站点,而且对确定这些肽上的所有聚糖结构都有特定的兴趣。正在开展这种方法的技术,包括开发软件以帮助解释。 http://sx102a.niddk.nih.gov上的实验室网站上的其他软件继续满足。随着人们对蛋白质相互作用的越来越多的了解,隔离蛋白质复合物并识别玩家的重要性是引人注目的。该小组正在与在该领域工作的几个研究小组进行互动,并开发了处理这些样本的技术。 特别令人感兴趣的是特定蛋白质组中所有蛋白质的鉴定。常见的方法是用胰蛋白酶消化整个蛋白质组,然后通过二维色谱法分解它。这个方法?丢弃?必须将所有色谱信息作为整个二维液体色谱运行,必须分析为一个搜索集。我们选择使用反相(C18)色谱法预先分离蛋白质,并分别消化并表征每个分数,因为这应该给出更简洁,更准确的搜索。使用了一些试验蛋白混合物后,我们选择使用立克西亚的蛋白质组。 Reckettsia是B级BioWarfare代理商,因此与NIH非常相关,根据这里的新计划。从阿拉巴马大学提供蛋白质样品,仅参与可溶性蛋白质。在蛋白质组中的834种蛋白质中,使用快速色谱和有限的数据采集在初始试验中鉴定了53个蛋白质。当尝试了更长的色谱运行时,该数字会扩展一点,但该方法远非优化。但是这个?蛋白质组?方法论远非优化,将成为进一步发展工作的主题。有关结果到目前为止的完整详细信息,请在http://sx102a.niddk.nih.gov/proteome.html上查看网站。 其他项目包括:(1)环化绿色荧光蛋白(GFP)的表征,该蛋白质(GFP)也被用作蛋白质组学方法的标签。循环酶相关的蛋白质,突变体蓝黄素和二氢叶酸还原酶已有效地表征。 (2)丝蛋白分子结构的表征。这需要开发方法来确定同位素富集的蛋白质。 (3)已经建立了一种类似的方法来识别和表征针对抗HIV和抗癌活性的天然产物中发现的异常氨基酸。 (4)我们正在研究与DNA和放线症Naeslundii Fimbriae交联HIV - 积极酶结构信息的方法。 (5)为了鉴定微管蛋白中最具反应性的位点,小管蛋白中的每一种半胱氨酸都与各种硫酰酯试剂反应。该方法将是蛋白质毒物结合研究以及了解微管蛋白聚合机制的非常重要的工具。 (6)正在研究一种表征TRH受体棕榈酰化通量的方法。这项研究对于了解环境变化触发翻译后修饰的方式以及为什么是为何重要。 该实验室进行了大量的Rountine分析,帮助来自NIH的调查人员。对蛋白质表征的需求已大大增加,以至于我们小组中已经建立了从研究所其他地方获得的新LCM,以供这些研究者动手使用。由五家机构共同购买的QTOF仪器几乎连续运行。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nitric oxide-mediated heme oxidation and selective beta-globin nitrosation of hemoglobin from normal and sickle erythrocytes.
一氧化氮介导的血红素氧化和正常红细胞和镰状红细胞血红蛋白的选择性β-珠蛋白亚硝化。
Corydendramines A and B, defensive natural products of the marine hydroid Corydendrium parasiticum.
紫堇胺 A 和 B,海洋水螅寄生紫堇的防御性天然产物。
  • DOI:
    10.1021/np000050h
  • 发表时间:
    2000
  • 期刊:
  • 影响因子:
    5.1
  • 作者:
    Lindquist,N;Shigematsu,N;Pannell,L
  • 通讯作者:
    Pannell,L
Small molecular products of dealkylation in soman-inhibited electric eel acetylcholinesterase.
梭曼抑制的电鳗乙酰胆碱酯酶脱烷基化的小分子产物。
  • DOI:
    10.1021/bi991112
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Viragh,C;Kovach,IM;Pannell,L
  • 通讯作者:
    Pannell,L
Intermolecular aggregations are responsible for the slow kinetics observed in the folding of cytochrome c at neutral pH.
分子间聚集是造成细胞色素 c 在中性 pH 条件下折叠动力学缓慢的原因。
  • DOI:
    10.1006/jmbi.1999.3226
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    5.6
  • 作者:
    Nawrocki,JP;Chu,RA;Pannell,LK;Bai,Y
  • 通讯作者:
    Bai,Y
Characterization of an enterotoxigenic Escherichia coli strain from Africa expressing a putative colonization factor.
来自非洲的表达推定定植因子的产肠毒素大肠杆菌菌株的表征。
  • DOI:
    10.1128/iai.67.8.4019-4026.1999
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Khalil,SB;Cassels,FJ;Shaheen,HI;Pannell,LK;El-Ghorab,N;Kamal,K;Mansour,M;Savarino,SJ;PeruskiJr,LF
  • 通讯作者:
    PeruskiJr,LF
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lewis K. Pannell其他文献

Procédés et compositions pour détecter un cancer du pancréas
胰腺癌检测程序和组合物
  • DOI:
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Lewis K. Pannell;Jana M. Rocker
  • 通讯作者:
    Jana M. Rocker
A new class of alkaloids from a dendrobatid poison frog: a structure for alkaloid 251F.
来自 dendrobatid 毒蛙的一类新生物碱:生物碱 251F 的结构。
  • DOI:
    10.1021/np50084a002
  • 发表时间:
    1992
  • 期刊:
  • 影响因子:
    5.1
  • 作者:
    T. Spande;H. Garraffo;H. Yeh;Q.;Lewis K. Pannell;John W. Daly
  • 通讯作者:
    John W. Daly
Primary structure of a novel neuropeptide isolated from the corpora cardiaca of periodical cicadas having adipokinetic and hypertrehalosemic activities.
从具有脂肪运动和高海藻糖活性的周期蝉贲门体中分离出的新型神经肽的一级结构。

Lewis K. Pannell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lewis K. Pannell', 18)}}的其他基金

A Novel Approach for the Routine Screening for Ovarian Cancer
卵巢癌常规筛查的新方法
  • 批准号:
    8551644
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
Profiling Urine Glycosylation of PSA and other Glyco-Biomarkers in Prostate Cance
分析前列腺癌中 PSA 和其他糖生物标志物的尿液糖基化
  • 批准号:
    7386271
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:
Profiling Urine Glycosylation of PSA and other Glyco-Biomarkers in Prostate Cance
前列腺癌中 PSA 和其他糖生物标志物的尿液糖基化分析
  • 批准号:
    7576898
  • 财政年份:
    2008
  • 资助金额:
    --
  • 项目类别:
Automated Glyco-Analysis of Cancer Related Proteins
癌症相关蛋白的自动糖分析
  • 批准号:
    7140158
  • 财政年份:
    2005
  • 资助金额:
    --
  • 项目类别:
Automated Glyco-Analysis of Cancer Related Proteins
癌症相关蛋白质的自动糖分析
  • 批准号:
    6961743
  • 财政年份:
    2005
  • 资助金额:
    --
  • 项目类别:
MASS SPECTROMETRY OF DRUGS, NATURAL PRODUCTS, PROTEINS, AND OLIGONUCLEOTIDES
药物、天然产物、蛋白质和寡核苷酸的质谱分析
  • 批准号:
    6105233
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MASS SPECTROMETRY OF DRUGS, NATURAL PRODUCTS, PROTEINS, AND OLIGONUCLEOTIDES
药物、天然产物、蛋白质和寡核苷酸的质谱分析
  • 批准号:
    6289766
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Mass Spectrometry Of Drugs, Natural Products, Proteins,
药物、天然产物、蛋白质的质谱分析,
  • 批准号:
    6507291
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MASS SPECTROMETRY OF DRUGS, NATURAL PRODUCTS, PROTEINS, AND OLIGONUCLEOTIDES
药物、天然产物、蛋白质和寡核苷酸的质谱分析
  • 批准号:
    6432107
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似国自然基金

核苷类抗病毒药物嵌合型核酸纳米载体的构筑及其抗病毒性能研究
  • 批准号:
    52303174
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
靶向病毒核衣壳蛋白质相分离的抗病毒药物发现及机制研究
  • 批准号:
    82302491
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
水环境中抗病毒药物及其转化副产物的识别及生态毒性效应研究
  • 批准号:
    52300245
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
猴痘病毒入侵融合复合物、DNA聚合酶复合物的结构解析以及抗病毒药物的开发
  • 批准号:
    82241081
  • 批准年份:
    2022
  • 资助金额:
    65.00 万元
  • 项目类别:
    专项项目
CCHFV的致病机理及抗病毒药物研究
  • 批准号:
    U22A20336
  • 批准年份:
    2022
  • 资助金额:
    255.00 万元
  • 项目类别:
    联合基金项目

相似海外基金

Broad spectrum inhibitors of paramyxovirus envelope proteins
副粘病毒包膜蛋白的广谱抑制剂
  • 批准号:
    10634368
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Anti-tick-borne Encephalitis Virus Miniprotein Agents
抗蜱传脑炎病毒微蛋白制剂
  • 批准号:
    7760475
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
Peptide Inhibitors of HIV-1 Vif Function
HIV-1 Vif 功能的肽抑制剂
  • 批准号:
    7230040
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
Anti-tick-borne Encephalitis Virus Miniprotein Agents
抗蜱传脑炎病毒微蛋白制剂
  • 批准号:
    7176235
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
Anti-tick-borne Encephalitis Virus Miniprotein Agents
抗蜱传脑炎病毒微蛋白制剂
  • 批准号:
    7348316
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了